Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Insiders ranked
752
Showing 50 of 752
Quality filters
10+ trades
≥3 issuers, 50% price coverage
Window
5y trailing
Trade date filter
| # | Insider | Trades | Issuers | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|
| 101 | Vhcp Management III, LLC | 42/58 | 3 | 74% | +10.5% | +10.4% | +35.5% | -14.5% |
| 102 | Venrock Healthcare Capital Partners Eg, L.P. | 42/58 | 3 | 74% | +10.5% | +10.4% | +35.5% | -14.5% |
| 103 | Venrock Healthcare Capital Partners III, L.P. | 42/58 | 3 | 74% | +10.5% | +10.4% | +35.5% | -14.5% |
| 104 | Enright Patrick G | 20/22 | 9 | 80% | +10.5% | +4.5% | +38.1% | -5.9% |
| 105 | Shah Nimish P | 43/59 | 4 | 74% | +10.4% | +10.0% | +35.5% | -14.5% |
| 106 | Carlton Pamela G | 16 | 4 | 81% | +10.1% | +13.9% | +16.6% | -7.6% |
| 107 | Dondero James D | 82/87 | 6 | 79% | +10.1% | +8.8% | +31.1% | -27.2% |
| 108 | Laffer Arthur B | 21/23 | 3 | 57% | +10.0% | +6.7% | +48.5% | -23.0% |
| 109 | Gordon Carl L | 32/59 | 9 | 53% | +9.8% | +6.7% | +68.9% | -26.9% |
| 110 | Orbimed Advisors LLC | 189/283 | 32 | 65% | +9.8% | +9.5% | +136.4% | -36.8% |
| 111 | Afeyan Noubar | 261/267 | 6 | 79% | +9.5% | +9.5% | +192.9% | -53.1% |
| 112 | Morningside Venture Investments Ltd | 36/38 | 3 | 86% | +9.4% | +8.2% | +24.3% | -5.5% |
| 113 | Sequoia Grove II, LLC | 27 | 3 | 52% | +9.3% | +15.9% | +36.5% | -19.7% |
| 114 | Sequoia Grove Manager, LLC | 27 | 3 | 52% | +9.3% | +15.9% | +36.5% | -19.7% |
| 115 | Mylod Robert J Jr | 33/42 | 3 | 94% | +9.3% | +3.8% | +17.0% | -4.8% |
| 116 | Maltz Jules A. | 12 | 3 | 83% | +9.1% | +3.4% | +41.8% | -17.4% |
| 117 | Paulson & Co. Inc. | 12 | 5 | 83% | +9.0% | +10.2% | +20.7% | -7.0% |
| 118 | Kolchinsky Peter | 195/229 | 32 | 47% | +8.9% | -2.0% | +141.5% | -38.0% |
| 119 | Ra Capital Healthcare Fund LP | 195/229 | 32 | 47% | +8.9% | -2.0% | +141.5% | -38.0% |
| 120 | Shah Rajeev M. | 195/229 | 32 | 47% | +8.9% | -2.0% | +141.5% | -38.0% |
| 121 | Opaleye Management Inc. | 242/283 | 9 | 67% | +8.9% | +6.4% | +85.6% | -40.7% |
| 122 | McGraner Matt | 13 | 3 | 69% | +8.9% | +4.3% | +33.2% | -13.3% |
| 123 | Polar Asset Management Partners Inc. | 15/30 | 11 | 67% | +8.9% | +3.4% | +29.2% | -2.6% |
| 124 | Ra Capital Management, L.P. | 197/231 | 33 | 47% | +8.8% | -1.0% | +141.5% | -38.0% |
| 125 | Lynx1 Capital Management LP | 31 | 5 | 65% | +8.7% | +6.8% | +33.9% | -31.7% |
| 126 | Nichols Weston | 31 | 5 | 65% | +8.7% | +6.8% | +33.9% | -31.7% |
| 127 | Manning Paul B | 24 | 4 | 58% | +8.6% | +7.5% | +70.5% | -29.2% |
| 128 | Chen Bihua | 134/147 | 14 | 60% | +8.4% | +11.6% | +45.9% | -56.8% |
| 129 | Saluja Dipender | 19 | 3 | 84% | +8.3% | +6.6% | +31.5% | -26.1% |
| 130 | Cannell Capital LLC | 60 | 3 | 63% | +8.3% | +9.5% | +66.5% | -40.2% |
| 131 | Icahn Carl C | 147 | 9 | 73% | +8.2% | +6.3% | +58.2% | -13.0% |
| 132 | Botha Roelof | 64/74 | 7 | 80% | +8.2% | +5.4% | +36.5% | -25.3% |
| 133 | Wolf Dale B | 14 | 3 | 79% | +8.2% | +8.0% | +23.4% | -9.1% |
| 134 | Oaktree Value Opportunities Fund Holdings, L.P. | 10/15 | 3 | 90% | +8.1% | +3.4% | +28.6% | -3.4% |
| 135 | 667, L.P. | 340/378 | 11 | 84% | +7.8% | +9.8% | +55.7% | -85.2% |
| 136 | Baker Brothers Life Sciences LP | 340/378 | 11 | 84% | +7.8% | +9.8% | +55.7% | -85.2% |
| 137 | Henry Christian O | 37 | 3 | 73% | +7.8% | +13.0% | +37.9% | -47.4% |
| 138 | Sb Investment Advisers (UK) Ltd | 124 | 5 | 76% | +7.8% | +6.8% | +48.8% | -20.0% |
| 139 | Heyer Andrew R | 66/67 | 4 | 65% | +7.8% | +5.2% | +49.0% | -19.1% |
| 140 | Casdin Capital, LLC | 73/83 | 4 | 70% | +7.8% | +6.3% | +39.1% | -31.0% |
| 141 | Casdin Eli | 73/86 | 4 | 70% | +7.8% | +6.3% | +39.1% | -31.0% |
| 142 | Casdin Partners Gp, LLC | 73/83 | 4 | 70% | +7.8% | +6.3% | +39.1% | -31.0% |
| 143 | Casdin Partners Master Fund, L.P. | 73/83 | 4 | 70% | +7.8% | +6.3% | +39.1% | -31.0% |
| 144 | Stone John H | 43 | 3 | 93% | +7.7% | +9.3% | +9.3% | -8.5% |
| 145 | Topline Capital Partners, LP | 69 | 7 | 62% | +7.6% | +2.5% | +58.4% | -17.6% |
| 146 | McBirney Collin | 69 | 7 | 61% | +7.5% | +2.5% | +58.4% | -17.6% |
| 147 | Topline Capital Management, LLC | 69 | 7 | 61% | +7.5% | +2.5% | +58.4% | -17.6% |
| 148 | Gustafson Kurt A | 14/18 | 3 | 71% | +7.5% | +7.6% | +31.1% | -20.5% |
| 149 | Oliver Eric L | 43/48 | 3 | 93% | +7.4% | +6.6% | +20.4% | -2.1% |
| 150 | Sr One Capital Management, LLC | 15/21 | 5 | 73% | +7.2% | +10.6% | +18.0% | -7.3% |